Abstract
Young adults below 35 years of age who do not have an exceedingly rare genetic disorder such as familial hypercholesterolemia are at very low short-term (5- to 10-year) risk for coronary heart disease (CHD), and lipid-lowering treatment at this stage in life is unlikely to provide any short-term
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have